Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 38,000 | 168,000 | 306,000 | 26,000 |
| Cost of revenue | 16,000 | 42,000 | 59,000 | 22,000 |
| Gross profit | 22,000 | 126,000 | 247,000 | 4,000 |
| Research and development | 733,000 | 536,000 | 519,000 | 898,000 |
| Selling, general and administrative | 2M | 2M | 2M | 2M |
| Operating income | −3M | −2M | −2M | −4M |
| Net income | −4M | −2M | −2M | −3M |
| Earnings per share | −0.08 | −0.04 | −0.07 | −0.07 |
| Earnings per share, diluted | −0.08 | −0.04 | −0.07 | −0.07 |
| Weighted average shares | 47M | 45M | 44M | 44M |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 6M | 8M | 4M | 5M | 15M |
| Receivables | — | 254,000 | 93,000 | 108,000 | — | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Depreciation and amortisation | 254,000 | 134,000 | 170,000 | 209,000 |
| Share-based compensation | 37,000 | — | — | — |
| Capital expenditure | 525,000 | 33,000 | 6,000 | 3,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Current assets | — | 7M | 9M | 9M | — | — |
| Property, plant and equipment | — | 929,000 | 561,000 | 636,000 | 722,000 | — |
| Total assets | — | 8M | 11M | 10M | — | — |
| Current liabilities | — | 3M | 2M | 2M | — | — |
| Short-term debt | — | 139,000 | 91,000 | 62,000 | — | — |
| Long-term debt | — | 24,000 | 47,000 | — | — | — |
| Total liabilities | — | 3M | 2M | 2M | — | — |
| Equity | — | 5M | 8M | 8M | 10M | 15M |
| Investing cash flow | 915,000 | 3M | 1M | −5M |
| Financing cash flow | −186,000 | 3M | −81,000 | −320,000 |